[ASAP] A Biologically Inert Tamoxifen-Derived Long-Lasting Hydrogel-Mediated Immunochemotherapy Can Mitigate Tumor Progression and Activate T Cell Immunity LikeLiked Date: December 4, 2025 Less than 1 MinRead Views: 27 Chemistry of Materials DOI: 10.1021/acs.chemmater.5c01071 Source: http://dx.doi.org/10.1021/acs.chemmater.5c01071 Tags:Materials Industry FacebookTwitterLinkedinWhatsAppTelegramEmail ALT-Lab-Ad-1ALT-Lab-Ad-2ALT-Lab-Ad-3ALT-Lab-Ad-4ALT-Lab-Ad-5ALT-Lab-Ad-6ALT-Lab-Ad-7ALT-Lab-Ad-8ALT-Lab-Ad-9ALT-Lab-Ad-10ALT-Lab-Ad-11ALT-Lab-Ad-12ALT-Lab-Ad-13 Recent Articles What’s Up: August 2026 Skywatching Tips from NASA Research July 31, 2026 Lifestyle July 31, 2026 Location-allocation with green logistics and transport modeling: consideration of carbon emissions, recycling processes, and shipping frequency Research July 31, 2026 Bioconversion of sludge waste by black soldier fly (Hermetia illucens) larvae: A review of the potential use of food and beverage industry sludge as... Waste Management July 31, 2026 NASA to Host Florida Event Celebrating American Air, Space Leadership Research July 31, 2026 Mapped: Where Cars Eat Up the Biggest Share of Income Finance & investments July 31, 2026 Interactive: The Heezen–Tharp World Ocean Floor Map Environmental News July 31, 2026 NAW files lawsuit challenging Colorado EPR law Packaging July 31, 2026 Axjo, Balcan, Detpak among international packaging companies expanding in US Packaging July 31, 2026 Tell us: have you installed renewable energy sources in your home? Energy July 31, 2026 Load more